 | • レポートコード：MRC2307A0078 • 出版社/出版日：Transparency Market Research / 2023年5月 • レポート形態：英文、PDF、228ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥869,250 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,319,250 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,769,250 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の当市場調査書によると、世界の生体吸収性血管足場市場規模が、2023年の161.5百万ドルから2031年までに316.7百万ドルに達し、予測期間中にCAGR（年平均成長率）7.8%で拡大すると予想されています。本書は、生体吸収性血管足場の世界市場を総合的に調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、主要インサイト、製品別（エベロリムス溶出装置、ノボリムス溶出装置、シロリムス溶出装置、その他）分析、疾患別（冠動脈疾患、末梢血管疾患）分析、材料別（ポリ-L-乳酸、チロシン由来ポリカーボネート、その他）分析、エンドユーザー別（病院、外来手術センター、心臓カテーテル研究室、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、中南米）分析、競争状況などの項目を掲載しています。なお、Kyoto Medical Planning Co., Ltd.、BIOTRONIK Group of Companies.、REVA Medical、Elixir Medical、Arterius、Meril Life Sciences Pvt. Ltd.、S3V Vascular Technologies、Zorion Medicalなど、主要企業情報が含まれています。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・主要インサイト ・世界の生体吸収性血管足場市場規模：製品別 - エベロリムス溶出装置の市場規模 - ノボリムス溶出装置の市場規模 - シロリムス溶出装置の市場規模 - その他製品の市場規模 ・世界の生体吸収性血管足場市場規模：疾患別 - 冠動脈疾患における市場規模 - 末梢血管疾患における市場規模 ・世界の生体吸収性血管足場市場規模：材料別 - ポリ-L-乳酸における市場規模 - チロシン由来ポリカーボネートにおける市場規模 - その他材料における市場規模 ・世界の生体吸収性血管足場市場規模：エンドユーザー別 - 病院における市場規模 - 外来手術センターにおける市場規模 - 心臓カテーテル研究室における市場規模 - その他エンドユーザーにおける市場規模 ・世界の生体吸収性血管足場市場規模：地域別 - 北米の生体吸収性血管足場市場規模 - ヨーロッパの生体吸収性血管足場市場規模 - アジア太平洋の生体吸収性血管足場市場規模 - 中東・アフリカの生体吸収性血管足場市場規模 - 中南米の生体吸収性血管足場市場規模 ・競争状況 |
Bioresorbable Vascular Scaffold Market – Scope of Report
TMR’s report on the global Bioresorbable Vascular Scaffold market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Bioresorbable Vascular Scaffold market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Bioresorbable Vascular Scaffold market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the Bioresorbable Vascular Scaffold market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Bioresorbable Vascular Scaffold market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Bioresorbable Vascular Scaffold market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Bioresorbable Vascular Scaffold market.
The report delves into the competitive landscape of the global Bioresorbable Vascular Scaffold market. Key players operating in the global Bioresorbable Vascular Scaffold market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Bioresorbable Vascular Scaffold market profiled in this report.
Key Questions Answered in Global Bioresorbable Vascular Scaffold Market Report
• What is the sales/revenue generated by Bioresorbable Vascular Scaffold across all regions during the forecast period?
• What are the opportunities in the global Bioresorbable Vascular Scaffold market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?
Bioresorbable Vascular Scaffold Market – Research Objectives and Research Approach
The comprehensive report on the global Bioresorbable Vascular Scaffold market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global Bioresorbable Vascular Scaffold market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Bioresorbable Vascular Scaffold market.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Bioresorbable Vascular Scaffold Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Development
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Bioresorbable Vascular Scaffold Market Analysis and Forecasts, 2017 – 2031
5. Key Insights
5.1. Technological Advancement
5.2. Disease Incidence and Prevalence
5.3. Regulatory Analysis
5.4. COVID-19 Impact Analysis
6. Global Bioresorbable Vascular Scaffold Market Analysis and Forecasts, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017 – 2031
6.3.1. Everolimus-eluting Device
6.3.2. Novolimus-eluting Device
6.3.3. Sirolimus-eluting Device
6.3.4. Others (Rapamycin, etc.)
6.4. Market Attractiveness Analysis, By Product Type
7. Global Bioresorbable Vascular Scaffold Market Analysis and Forecasts, by Disease Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Disease Type, 2017 – 2031
7.3.1. Coronary Artery Disease
7.3.2. Peripheral Artery Disease
7.4. Market Attractiveness Analysis, By Disease Type
8. Global Bioresorbable Vascular Scaffold Market Analysis and Forecasts, by Material Type
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Material Type, 2017 – 2031
8.3.1. Poly-L-Lactic Acid (PLLA)
8.3.2. Tyrosine-derived Polycarbonate
8.3.3. Others (Polydioxanone, etc.)
8.4. Market Attractiveness Analysis, By Material Type
9. Global Bioresorbable Vascular Scaffold Market Analysis and Forecasts, by End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by End-user, 2017 – 2031
9.3.1. Hospital
9.3.2. Ambulatory Surgical Center
9.3.3. Cardiac Catheterization Lab
9.3.4. Others (Research Institute, etc.)
9.4. Market Attractiveness Analysis, By End-user
10. Global Bioresorbable Vascular Scaffold Market Analysis and Forecasts, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, By Region
11. North America Bioresorbable Vascular Scaffold Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017 – 2031
11.2.1. Everolimus-eluting Device
11.2.2. Novolimus-eluting Device
11.2.3. Sirolimus-eluting Device
11.2.4. Others (Rapamycin, etc.)
11.3. Market Value Forecast, by Disease Type, 2017 – 2031
11.3.1. Coronary Artery Disease
11.3.2. Peripheral Artery Disease
11.4. Market Value Forecast, by Material Type, 2017 – 2031
11.4.1. Poly-L-Lactic Acid (PLLA)
11.4.2. Tyrosine-derived Polycarbonate
11.4.3. Others (Polydioxanone, etc.)
11.5. Market Value Forecast, by End-user, 2017 – 2031
11.5.1. Hospital
11.5.2. Ambulatory Surgical Center
11.5.3. Cardiac Catheterization Lab
11.5.4. Others (Research Institute, etc.)
11.6. Market Value Forecast, by Country, 2017 – 2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Product Type
11.7.2. By Disease Type
11.7.3. By Material Type
11.7.4. By End-user
11.7.5. By Country
12. Europe Bioresorbable Vascular Scaffold Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017 – 2031
12.2.1. Everolimus-eluting Device
12.2.2. Novolimus-eluting Device
12.2.3. Sirolimus-eluting Device
12.2.4. Others (Rapamycin, etc.)
12.3. Market Value Forecast, by Disease Type, 2017 – 2031
12.3.1. Coronary Artery Disease
12.3.2. Peripheral Artery Disease
12.4. Market Value Forecast, by Material Type, 2017 – 2031
12.4.1. Poly-L-Lactic Acid (PLLA)
12.4.2. Tyrosine-derived Polycarbonate
12.4.3. Others (Polydioxanone, etc.)
12.5. Market Value Forecast, by End-user, 2017 – 2031
12.5.1. Hospital
12.5.2. Ambulatory Surgical Center
12.5.3. Cardiac Catheterization Lab
12.5.4. Others (Research Institute, etc.)
12.6. Market Value Forecast, by Country/Sub-region, 2017 – 2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Product Type
12.7.2. By Disease Type
12.7.3. By Material Type
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Bioresorbable Vascular Scaffold Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017 – 2031
13.2.1. Everolimus-eluting Device
13.2.2. Novolimus-eluting Device
13.2.3. Sirolimus-eluting Device
13.2.4. Others (Rapamycin, etc.)
13.3. Market Value Forecast, by Disease Type, 2017 – 2031
13.3.1. Coronary Artery Disease
13.3.2. Peripheral Artery Disease
13.4. Market Value Forecast, by Material Type, 2017 – 2031
13.4.1. Poly-L-Lactic Acid (PLLA)
13.4.2. Tyrosine-derived Polycarbonate
13.4.3. Others (Polydioxanone, etc.)
13.5. Market Value Forecast, by End-user, 2017 – 2031
13.5.1. Hospital
13.5.2. Ambulatory Surgical Center
13.5.3. Cardiac Catheterization Lab
13.5.4. Others (Research Institute, etc.)
13.6. Market Value Forecast, by Country/Sub-region, 2017 – 2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Product Type
13.7.2. By Disease Type
13.7.3. By Material Type
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Bioresorbable Vascular Scaffold Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017 – 2031
14.2.1. Everolimus-eluting Device
14.2.2. Novolimus-eluting Device
14.2.3. Sirolimus-eluting Device
14.2.4. Others (Rapamycin, etc.)
14.3. Market Value Forecast, by Disease Type, 2017 – 2031
14.3.1. Coronary Artery Disease
14.3.2. Peripheral Artery Disease
14.4. Market Value Forecast, by Material Type, 2017 – 2031
14.4.1. Poly-L-Lactic Acid (PLLA)
14.4.2. Tyrosine-derived Polycarbonate
14.4.3. Others (Polydioxanone, etc.)
14.5. Market Value Forecast, by End-user, 2017 – 2031
14.5.1. Hospital
14.5.2. Ambulatory Surgical Center
14.5.3. Cardiac Catheterization Lab
14.5.4. Others (Research Institute, etc.)
14.6. Market Value Forecast, by Country/Sub-region, 2017 – 2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Product Type
14.7.2. By Disease Type
14.7.3. By Material Type
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Bioresorbable Vascular Scaffold Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product Type, 2017 – 2031
15.2.1. Everolimus-eluting Device
15.2.2. Novolimus-eluting Device
15.2.3. Sirolimus-eluting Device
15.2.4. Others (Rapamycin, etc.)
15.3. Market Value Forecast, by Disease Type, 2017 – 2031
15.3.1. Coronary Artery Disease
15.3.2. Peripheral Artery Disease
15.4. Market Value Forecast, by Material Type, 2017 – 2031
15.4.1. Poly-L-Lactic Acid (PLLA)
15.4.2. Tyrosine-derived Polycarbonate
15.4.3. Others (Polydioxanone, etc.)
15.5. Market Value Forecast, by End-user, 2017 – 2031
15.5.1. Hospital
15.5.2. Ambulatory Surgical Center
15.5.3. Cardiac Catheterization Lab
15.5.4. Others (Research Institute, etc.)
15.6. Market Value Forecast, by Country/Sub-region, 2017 – 2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Product Type
15.7.2. By Disease Type
15.7.3. By Material Type
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (By Tier and Size of companies)
16.2. Market Share Analysis By Company (2021)
16.3. Company Profiles
16.3.1. Kyoto Medical Planning Co., Ltd.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Test Type Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. BIOTRONIK Group of Companies
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Test Type Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. REVA Medical
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Test Type Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Elixir Medical
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Test Type Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Arterius
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Test Type Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Meril Life Sciences Pvt. Ltd
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Test Type Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. S3V Vascular Technologies
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Test Type Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Zorion medical
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Test Type Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Medtronic (development phase)
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Test Type Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
Table 01: Global Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 02: Global Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031
Table 03: Global Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Material Type, 2017-2031
Table 04: Global Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 05: Global Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 06: North America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 07: North America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 08: North America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031
Table 09: North America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Material Type, 2017-2031
Table 10: North America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 11: Europe Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 12: Europe Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 13: Europe Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031
Table 14: Europe Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Material Type, 2017-2031
Table 15: Europe Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 16: Asia Pacific Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 17: Asia Pacific Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 18: Asia Pacific Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031
Table 19: Asia Pacific Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Material Type, 2017-2031
Table 20: Asia Pacific Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 21: Latin America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 22: Latin America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 23: Latin America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031
Table 24: Latin America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Material Type, 2017-2031
Table 25: Latin America Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 26: Middle East & Africa Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 27: Middle East & Africa Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 28: Middle East & Africa Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Disease Type, 2017-2031
Table 29: Middle East & Africa Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by Material Type, 2017-2031
Table 30: Middle East & Africa Bioresorbable Vascular Scaffold Market Value (US$ Mn) Forecast, by End-user, 2017-2031
